This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Site Search
Showing 11 - 11 of 11 results
Press Release
|
Oct. 21, 2019
|
3 min read